PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2013151
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2013151
Gene Synthesis Market size was valued at US$ 4,302.11 Million in 2025, expanding at a CAGR of 21.99% from 2026 to 2033.
Gene synthesis refers to the artificial creation of genes through chemical processes in synthetic biology, where DNA sequences are constructed in laboratories without using natural templates. It involves two key steps, including the synthesis of short oligonucleotides and their assembly into full gene sequences. Gene synthesis supports Application such as protein production, molecular cloning, and protein engineering while reducing time and cost compared to conventional methods.
The gene synthesis market is being transformed by artificial intelligence, which enhances speed, accuracy, and scalability while enabling precise DNA sequence design and reducing errors in gene assembly. For instance, in May 2023, GenScript announced the launch of GenTitan, the world's first commercial semiconductor platform for DNA synthesis. This advanced platform powers GenScripts latest gene fragment synthesis service. With the introduction of GenTitan, GenScript has achieved the highest acceptance rate for complex sequences and is now able to provide custom synthetic genes at a remarkably low price compared to industry standards. The gene synthesis market is therefore growing rapidly due to AI advancements that improve efficiency, scalability, and cost-effectiveness.
Gene Synthesis Market- Market Dynamics
Rising adoption of precision medicine to drive market growth
The increasing demand for precision medicine is driving the growth of gene synthesis, as it enables the development of targeted therapies based on individual genetic profiles for improved treatment outcomes. By World Economic Forum, the rapid adoption of precision medicine, driven by genomics, AI innovations, and rising investments, is transforming healthcare and fueling economic growth. For instance, in Nov 2024, according to a study published on PubMed Central, precision medicine research recorded a significant rise, with 5,128 publications in a single year, reflecting strong global research growth. The study further highlights that participation expanded from 3 countries in 1999 to 80 countries by 2022, indicating widespread adoption. Therefore, the gene synthesis market is growing due to rising adoption and advances in precision medicine.
The Global Gene Synthesis Market is segmented on the basis of Product, Services, Use Case, Technology, Application, End User, and Region.
Gene synthesis based on product type shows that linear double-stranded gene fragments (dsDNA) hold a significant share, driven by their extensive use in gene assembly, cloning, and therapeutic Application. In March 2025, Integrated DNA Technologies, Inc. partnered with Elegen to introduce long and complex clonal gene synthesis solutions up to 15 kb, enabling rapid production of high-quality double-stranded DNA for advanced research and therapeutic development. The gene synthesis market is therefore experiencing growth due to increasing demand for high-quality dsDNA solutions in advanced research and therapeutic Application.
In terms of technology, polymerase chain reaction (PCR), oligonucleotide synthesis, gene assembly, and site-directed mutagenesis represent key segments, driven by their extensive use in gene construction, research Application, and therapeutic development. For instance, in April 2023, according to the UK Health Security Agency, the National Testing Programme (NTP) deployed PCR testing for SARS-CoV-2 across the country. The report notes that daily PCR testing peaked at several hundred thousand samples, supporting clinical needs. By the end of 2023, PCR testing infrastructure supported rapid infection detection, contact tracing, and public health monitoring nationwide. PCR and related technologies play a key role in gene research, diagnostics, and public health.
Gene Synthesis Market- Geographical Insights
Gene synthesis on the basis of geography, North America is expected to see significant growth in the gene synthesis market, driven by expanding research and development, innovations in gene technologies, and increased adoption of gene therapy. For example, in March 2025, the Scientific Advancements in Gene Therapies article on PMC reported that while over 2,000 gene therapies were under development worldwide, fewer than five clinical trials were underway in regions with a significant share of the global genetic disease burden, underscoring major disparities in research attention. North America's gene synthesis growth is driven by R&D, innovations, and rising gene therapy adoption.
The Asia Pacific region is expected to register significant growth during the forecast period. This expansion is driven by increasing government investment in biotechnology, genetic engineering, agriculture, healthcare, and ongoing technological advancements. For instance, in April 2025, according to the MERICS Org report, China's biotechnology sector received consistent public R&D funding exceeding 2,800 million USD in 2023, and Chinese labs produced 3-4 times more biotech publications than Europe by 2022. In 2023, China led global output in synthetic biology (61% share), genomic sequencing (42%), and biological manufacturing (29%). These trends highlight the Asia Pacific's growing prominence in biotechnology research and innovation.
Brazil Gene Synthesis Market - Country Insights
Brazil is strengthening its presence in the gene synthesis market, driven by the rising prevalence of genetic disorders, growing adoption of gene therapies, and increasing disposable incomes. For instance, in 2025, according to the (OECD) Org, real household disposable income per capita in OECD countries grew modestly through 2025, with increases of 0.1% in Q1 and 0.3% in Q3, underscoring gradual improvements in households' economic capacity. In Brazil, disposable income trends mirrored global patterns, reflecting gradual recovery and increasing consumer purchasing power. These trends indicate a gradual strengthening of Brazil's market potential through rising consumer purchasing power and economic recovery.
The global gene synthesis market is highly competitive and fragmented, with numerous players operating at global, regional, and country levels. Only a few companies hold significant market shares, intensifying rivalry as they compete for dominance. Key players in the market include Thermo Fisher Scientific Inc., GenScript, Integrated DNA Technologies Inc., Twist Bioscience, and Merck KGaA .In February 2023, Integrated DNA Technologies (IDT) announced the launch of its new MiniGene Synthetic Genes service. The service offers a convenient way to obtain synthetic genes that are less than 5000 bp in length. These developments reflect ongoing innovation and competitive strategies driving growth in the global gene synthesis market.
In February 2024, Ansa Biotechnologies, Inc., a leader in next-generation DNA synthesis, appointed Jason T. Gammack as CEO as the company prepares to launch its full commercial service and conclude its early access program for complex synthetic genes. Founding CEO Dan Lin-Arlow, PhD, will transition to the role of chief scientific officer.
In 25 April 2024, Merck KGaA announced an investment of more than $320 million to establish a new Advanced Life Science Research Center at its global headquarters in Darmstadt, Germany, to support research on key biotechnological technologies including manufacturing processes that enable advanced genetic and biological production.